The Lancet (British edition), 2017-05, Vol.389 (10081), p.1773-1775
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes
- Ist Teil von
- The Lancet (British edition), 2017-05, Vol.389 (10081), p.1773-1775
- Ort / Verlag
- England: Elsevier Ltd
- Erscheinungsjahr
- 2017
- Quelle
- Elsevier ScienceDirect Journals
- Beschreibungen/Notizen
- Building on ATLAS-ACS 2 and the above evidence supporting aspirin abandonment, E Magnus Ohman and colleagues9 report in The Lancet results from the randomised GEMINI-ACS-1 trial, the first large attempt (n=3037 patients from 371 sites in 21 countries) to replace the acute coronary syndrome therapy cornerstone. The investigators and sponsor should be congratulated for conducting thoughtful and exciting research.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0140-6736eISSN: 1474-547XDOI: 10.1016/S0140-6736(17)30760-2Titel-ID: cdi_proquest_miscellaneous_1880079787
- Format
- –
- Schlagworte
- Abandonment, Acute Coronary Syndrome, Acute coronary syndromes, Aspirin, Aspirin - therapeutic use, Blood platelets, Clinical trials, Coronary vessels, Disorders, Drug therapy, Fibrinolytic Agents, Humans, Internal Medicine, Platelet Aggregation Inhibitors, Rivaroxaban - therapeutic use, Therapy, Thrombosis